Novel Drug Delivery Systems for Cancer Therapy Market
Novel Drug Delivery Systems for Cancer Therapy
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Novel Drug Delivery Systems for Cancer Therapy
Market Size and Growth
The global Novel Drug Delivery Systems for Cancer Therapy market is experiencing significant growth, projected to exceed USD 25 billion by 2028. Factors driving this expansion include advancements in targeted therapies, increasing cancer prevalence, and innovations in delivery technologies. Competitive dynamics highlight key players focusing on enhancing efficacy and precision in treatment.
Companies Covered
(Covid 19 Impact Covered)
◍ Advanced Medical Isotope Corporation
◍ Bind Therapeutics
◍ Boston Scientific Corporation
◍ BTG plc
◍ CeloNova BioSciences, Inc.
◍ Cook Medical, Inc.
◍ Cospheric LLC
◍ Covidien, plc
◍ Eckert & Ziegler BEBIG
◍ EmboMedics, Inc.
◍ Kobo Products, Inc.
◍ Merit Medical Systems, Inc.
◍ Mo-Sci Corporation
◍ Nanobiotix
◍ Polysciences, Inc.
◍ Sirtex Medical, Inc.
◍ Terumo Corporation
The Novel Drug Delivery Systems for Cancer Therapy Market features companies like Advanced Medical Isotope Corporation and Nanobiotix, employing innovative targeted therapies and nanoparticles. They enhance treatment efficacy and patient outcomes, driving market growth. Sales revenues include:
- Boston Scientific: $13.2 billion
- Cook Medical: $3 billion
- Terumo: $4.2 billion.
Request Sample Report
Market Segmentation
By Application
◍ Clinics
◍ Others
By Product
◍ Embolization Particles – Drug Eluting Beads
◍ Holmium-Based Microspheres ◍ Liquid Embolics – Onyx ◍ Other ◍ Hospitals
◍ Polyvinyl Alcohol Particles
◍ Microspheres
◍ Gelatin-Based Embolization
Devices
◍ Selective Internal Radiation
Therapy
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
